1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > South Korea Clinical Chemistry Market Outlook to 2021

South Korea Clinical Chemistry Market Outlook to 2021

  • October 2015
  • -
  • Global Data
  • -
  • 38 pages

South Korea Clinical Chemistry Market Outlook to 2021

Summary

GlobalData’s new report, "South Korea Clinical Chemistry Market Outlook to 2021", provides key market data on the South Korea Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Clinical Chemistry market.
- Global corporate-level profiles of key companies operating within the South Korea Clinical Chemistry market.
- Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

South Korea Clinical Chemistry Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Clinical Chemistry Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Clinical Chemistry Market, South Korea 9
3.1 Clinical Chemistry Market, South Korea, Revenue ($m), 2007-2014 9
3.2 Clinical Chemistry Market, South Korea, Revenue ($m), 2014-2021 11
3.2.1 Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), by Segment, 2007-2014 13
3.2.2 Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), by Segment, 2007-2014 15
3.2.3 Urine Analysis Market, South Korea, Revenue ($m), by Segment, 2007-2014 17
3.2.4 Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), by Segment, 2014-2021 19
3.2.5 Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), by Segment, 2014-2021 21
3.2.6 Urine Analysis Market, South Korea, Revenue ($m), by Segment, 2014-2021 23
3.3 Clinical Chemistry Market, South Korea, Distribution Share by Revenue ($m), 2013-2014 25
3.4 Clinical Chemistry Market, South Korea, Company Share by Revenue ($m), 2014 26
4 Overview of Key Companies in South Korea, Clinical Chemistry Market 28
4.1 Siemens Healthcare 28
4.1.1 Company Overview 28
4.2 Bio-Rad Laboratories, Inc. 28
4.2.1 Company Overview 28
4.3 F. Hoffmann-La Roche Ltd. 28
4.3.1 Company Overview 28
4.4 Danaher Corporation 29
4.4.1 Company Overview 29
4.5 Toshiba Medical Systems Corporation 29
4.5.1 Company Overview 29
4.6 Abbott Laboratories 29
4.6.1 Company Overview 29
4.7 Sysmex Corporation 29
4.7.1 Company Overview 29
4.8 Ortho-Clinical Diagnostics Inc. 30
4.8.1 Company Overview 30
5 Clinical Chemistry Market Pipeline Products 31
6 Financial Deals Landscape 34
6.1 Partnerships 34
6.1.1 NoemaLife Enters into Distribution Agreement with Horiba Medical 34
7 Appendix 35
7.1 Research Methodology 36
7.1.1 Coverage 36
7.1.2 Secondary Research 36
7.1.3 Primary Research 36
7.1.4 Company Share Analysis 37
7.1.5 Distribution Share Analysis 37
7.2 GlobalData Consulting 37
7.3 Contact Us 37
7.4 Disclaimer 38

1.1 List of Tables
Table 1: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 10
Table 2: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 12
Table 3: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 14
Table 4: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 16
Table 5: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 18
Table 6: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 20
Table 7: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 22
Table 8: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 24
Table 9: Clinical Chemistry Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014 25
Table 10: Clinical Chemistry Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014 27
Table 11: Clinical Chemistry Market Pipeline Products 31
Table 12: NoemaLife Enters into Distribution Agreement with Horiba Medical 34

1.2 List of Figures
Figure 1: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 9
Figure 2: Clinical Chemistry Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Figure 3: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 13
Figure 4: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 15
Figure 5: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014 17
Figure 6: Clinical Chemistry Analyzers Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 19
Figure 7: Therapeutic Drug Monitoring Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 21
Figure 8: Urine Analysis Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Figure 9: Clinical Chemistry Market, South Korea, Company Share (%) 2014 26

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 35000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Asia-Pacific diagnostic testing market, including Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, ...

2017 Middle East Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Middle East Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 24500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Middle East diagnostic testing market, including Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.